XNAS
STLNW
Market cap682mUSD
Sep 18, Last price
0.02USD
1D
-40.41%
1Q
-66.28%
IPO
-99.19%
Name
Oncology Institute Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DFP Healthcare Acquisitions Corp., founded in 2019 and headquartered in New York, aims to acquire various businesses or their assets. These acquisitions can be executed through several methods, including mergers, exchanges of capital stock, direct stock purchases, corporate reorganizations, or other comparable strategic combinations.
Key people
Independent Chairman of the Board · since 2021
Daniel Virnich
Chief Executive Officer, Director · since 2023
Brad Hively
Independent Vice Chairman of the Board · since 2023
Robert Carter
Chief Financial Officer, Principal Accounting Officer · since 2024
Nolan Mariano
Chief People Officer · since 2026
Kristin England
Chief Administrative Officer · since 2025
Rakesh Panda
Chief Information Officer · since 2026
Yale Podnos
Chief Medical Officer · since 2021
Karen Johnson
Independent Director · since 2021
Mohit Kaushal
Independent Director · since 2020
Anne Mcgeorge
Independent Chairman of the Board · since 2025
Mark Pacala
Independent Director · since 2022
Independent Director · since 2026
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||